Generate alzheimer's disease and related dementia (ADRD) patient-derived ipsc lines
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00245
- Awardee
-
New York Stem Cell Foundation Inc. UEI ZCKCL8KFL3B9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,700,000
Award facts
- Opportunity
-
- SOURCES SOUGHT: Generate Alzheimer’s Disease and Related Dementia (ADRD) patient-derived iPSC lines Pre-Solicitation · 75N95022Q00098 · Posted Jan 24, 2022
- Contract value 50% obligated
-
- $1,700,000.00 Current, with exercised options
- $3,400,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10019, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,700,000 |
About this award
The National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a firm-fixed price purchase order valued at $3.4 million to New York Stem Cell Foundation Inc. The contract calls for the contractor to generate up to 200 induced pluripotent stem cell lines derived from fresh whole blood or peripheral blood mononuclear cells of patients with Alzheimer's disease or related dementias. The cell lines must be collected by June 30, 2023 under the base year of performance, with an optional one-year extension to June 30, 2024. No set-aside provisions applied to this solicitation, which had an estimated value exceeding the $16.5 million small business size standard for the applicable NAICS code of 541990, Other Scientific and Technical Consulting Services.
Quick answers
Who was awarded contract 75N95022P00245?
75N95022P00245 was awarded to New York Stem Cell Foundation Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 24, 2022.
How much is contract 75N95022P00245 worth?
The government has obligated $1,700,000 on 75N95022P00245. Its potential value, with all options, is $3,400,000.
Which agency awarded contract 75N95022P00245?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00245, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95022P00245 competed?
The extent of competition for 75N95022P00245 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award